Taysha Gene Therapies is planning a webinar and invites the CLN1 disease community to submit questions about the TSHA-118 CLN1 Batten disease clinical trial to the patient advocacy groups BDSRA and BDFA.
Please submit your questions by February 20th, 2022 to Lisa at, admin@bdfa-uk.org.uk at the BDFA.
Please read the community letter HERE for more details.